SCM
NVO

Sterling Capital Management’s Novo Nordisk NVO Stock Holding History

Sterling Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.86M Buy
50,599
+6,827
+16% +$323K 0.04% 347
2025
Q4 		$2.23M Buy
43,772
+3,664
+9% +$187K 0.04% 359
2025
Q3 		$2.23M Buy
40,108
+4,146
+12% +$243K 0.03% 356
2025
Q2 		$2.48M Buy
35,962
+11,375
+46% +$774K 0.04% 322
2025
Q1 		$1.71M Buy
24,587
+6,110
+33% +$505K 0.03% 411
2024
Q4 		$1.59M Sell
18,477
-1,164
-6% -$126K 0.02% 488
2024
Q3 		$2.34M Buy
+19,641
New +$2.62M 0.03% 346
2019
Q3 		$481K Buy
18,626
+452
+2% +$11.4K ﹤0.01% 760
2019
Q2 		$464K Sell
18,174
-248
-1% -$6.13K ﹤0.01% 765
2019
Q1 		$482K Sell
18,422
-4,168
-18% -$102K ﹤0.01% 753
2018
Q4 		$520K Buy
22,590
+228
+1% +$5.07K 0.01% 736
2018
Q3 		$527K Buy
22,362
+50
+0.2% +$1.22K ﹤0.01% 781
2018
Q2 		$515K Sell
22,312
-678
-3% -$16.1K ﹤0.01% 755
2018
Q1 		$566K Buy
22,990
+402
+2% +$10.6K 0.01% 742
2017
Q4 		$606K Buy
22,588
+30
+0.1% +$763 0.01% 744
2017
Q3 		$543K Buy
22,558
+1,920
+9% +$43.4K 0.01% 755
2017
Q2 		$443K Sell
20,638
-9,436
-31% -$190K ﹤0.01% 789
2017
Q1 		$515K Sell
30,074
-2,748
-8% -$47.8K ﹤0.01% 788
2016
Q4 		$588K Sell
32,822
-47,814
-59% -$867K 0.01% 753
2016
Q3 		$1.68M Buy
80,636
+6,406
+9% +$159K 0.02% 425
2016
Q2 		$2M Buy
74,230
+58,746
+379% +$1.61M 0.02% 388
2016
Q1 		$420K Buy
15,484
+564
+4% +$15.1K ﹤0.01% 775
2015
Q4 		$433K Sell
14,920
-2,316
-13% -$64.1K ﹤0.01% 801
2015
Q3 		$467K Buy
+17,236
New +$488K ﹤0.01% 773

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Sterling Capital Management's NVO Position: Q1 2026 in Review

Sterling Capital Management increased its Novo Nordisk (NVO) stake by 16% in Q1 2026, buying an estimated $323K and bringing the position to 50,599 shares worth $1.86M. The position accounts for 0.04% of the portfolio, ranked #347.

Sterling Capital Management first reported a position in NVO in Q3 2015 and has held it in 24 quarters since. The position peaked at $2.48M in Q2 2025. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Sterling Capital Management held 50,599 shares of Novo Nordisk worth $1.86M as of Q1 2026.
  • Sterling Capital Management bought 6,827 Novo Nordisk shares in Q1 2026, an estimated $323K.
  • Novo Nordisk made up 0.04% of Sterling Capital Management's portfolio in Q1 2026, its #347 holding.
  • Sterling Capital Management first reported a position in Novo Nordisk in Q3 2015 and has held it in 24 quarters since.
  • Sterling Capital Management's Novo Nordisk position peaked at $2.48M in Q2 2025.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.